The global incidence of diabetes continues to increase at an exponential rate, in tandem with the rapid rise of obesity. Obesity, due to gene-environment interactions, is also associated with the development of other debilitating chronic conditions such as cardiovascular disease, cancer, Alzheimer's disease and asthma. Osteoporosis is an under-recognised and undertreated disorder that has a strong genetic basis. Excess and deficiency of pituitary hormones can cause significant disease, including diabetes, obesity and osteoporosis.
Our goals
The Endocrinology Department at St Vincent’s Hospital and the Garvan Institute of Medical Research contribute to the worldwide effort to understand the causal relationships between genetics, the environment, and the development of diabetes, obesity and osteoporosis. With expertise in basic science and clinical research, we aim to establish an accurate picture of the circumstances under which obesity precipitates diabetes to enable the prediction, prevention, and treatment of metabolic disease. We are also investigating the genetics of osteoporosis and pituitary conditions.
Research Strengths
Our results
We provide leadership in endocrinology, diabetes, obesity and metabolism research locally, nationally and internationally through our commitment to research, teaching and training, advisory roles and collaborations.
Our experts
Head, St Vincent's Clinical Campus, UNSW; Head, Department of Endocrinology, St Vincent's Hospital
View Profile
Our affiliated partners
UNSW Medicine and Health Medicine & Health - UNSW Sydney
St Vincent’s Research Campus One campus - St Vincent's Research Centre (svrc.one)
The Garvan Institute of Medical Research Garvan Institute of Medical Research